The science
The peptide with real clinical evidence in this complex is palmitoyl pentapeptide-4, pal-KTTKS, and its data set the standard for what a topical peptide can and cannot show. Robinson and colleagues' 2005 study in the International Journal of Cosmetic Science ran a twelve-week, double-blind, placebo-controlled, split-face trial in 93 women aged 35 to 55 comparing a moisturiser with 3 ppm pal-KTTKS against the same moisturiser without it, and found significant improvement in wrinkles and fine lines by both image analysis and expert grading, with good tolerance (https://pubmed.ncbi.nlm.nih.gov/18492182/). Two things follow for this serum. First, a low list position is compatible with an active dose, since the trial concentration was parts per million. Second, the effect took twelve weeks to demonstrate and concerned wrinkles, not pores, so Biodance's seven-day and four-week measurements cannot be attributed to it. A 2014 study in Biomolecules & Therapeutics on the dermal stability and skin permeation of KTTKS and its palmitoylated form found that the palmitoyl group improved penetration and stability but that permeation into skin remained limited, a reminder that delivery, not signalling, is the bottleneck for topical peptides (https://pubmed.ncbi.nlm.nih.gov/25143811/). The other nine peptides, including acetyl hexapeptide-8, copper tripeptide-1 and sh-oligopeptide-1, have laboratory and small cosmetic studies of varying quality but nothing at this formulation. The measurable pore effect is better explained by the base. Low-molecular collagen water is a surface humectant and film-former; PVM/MA copolymer and the acrylate polymers set into a flexible film that smooths pore rims; and niacinamide, which has controlled data for reducing sebum excretion and improving the appearance of pores over four to eight weeks of daily use, is the most likely active contributor to the four-week numbers. Biodance's study, conducted by P&K Skin Research Center on 23 women between February and March 2025, reported pore-depth and pore-area reductions of roughly 21 to 23 percent at four weeks; it is unpublished, brand-funded and lacked a vehicle comparator, so it demonstrates that the product works cosmetically without showing which ingredient is responsible. The 178.99 percent collagen production figure is an in-vitro result and does not describe skin.
References 2 ShowHide
- Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin — International Journal of Cosmetic Science (2005)
- Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS) — Biomolecules & Therapeutics (2014)